Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS
Masaaki Tanaka(Shinshu University), Tadao Akizawa(Showa University), Y. Asano(SHOWA Medical University), Akira Saitō(Fukushima Medical University), Yasuaki Hayashino(SHOWA Medical University), Shin Yamazaki, F. K. Port(SHOWA Medical University), Shinichi Fukuhara(University of Michigan), K. Kurokawa(Tokai University), T. Akiba(Tokyo Women's Medical University)
Cited by 36
Related Papers
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
|American Journal of Kidney Diseases|1998|2.4k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2006|628
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
|Kidney International|2016|474
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS
|Kidney International|2006|453